memantine has been researched along with Cancer of Prostate in 2 studies
Excerpt | Relevance | Reference |
---|---|---|
"Memantine is an FDA-approved Alzheimer's drug." | 1.48 | Memantine induces apoptosis and inhibits cell cycle progression in LNCaP prostate cancer cells. ( Albayrak, G; Bilen, CY; Dikmen, AU; Konac, E, 2018) |
"Of 18 benign prostatic hyperplasia (BPH) specimens, none had stromal NMDAr staining, but 2 had low and 1 had high epithelial NMDAr immunoreactivity." | 1.33 | N-methyl-D-aspartate receptor in human prostate cancer. ( Abdul, M; Hoosein, N, 2005) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Albayrak, G | 1 |
Konac, E | 1 |
Dikmen, AU | 1 |
Bilen, CY | 1 |
Abdul, M | 1 |
Hoosein, N | 1 |
2 other studies available for memantine and Cancer of Prostate
Article | Year |
---|---|
Memantine induces apoptosis and inhibits cell cycle progression in LNCaP prostate cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Cell Cycle; Cell Cycle Proteins; Ce | 2018 |
N-methyl-D-aspartate receptor in human prostate cancer.
Topics: Breast; Cell Line; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Cysteine; Dizocilpine Ma | 2005 |